Literature DB >> 16103163

Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population.

Margaret Conacher1, Robin Callard, Karen McAulay, Helen Chapel, David Webster, Dinakantha Kumararatne, Anita Chandra, Gavin Spickett, Paul A Hopwood, Dorothy H Crawford.   

Abstract

Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that persists in the body for life after primary infection. The primary site of EBV persistence is the memory B lymphocyte, but whether the virus initially infects naïve or memory B cells is still disputed. We have analyzed EBV infection in nine cases of X-linked hyper-immunoglobulin M (hyper-IgM) syndrome who, due to a mutation in CD40 ligand gene, do not have a classical, class-switched memory B-cell population (IgD(-) CD27(+)). We found evidence of EBV infection in 67% of cases, which is similar to the infection rate found in the general United Kingdom population (60 to 70% for the relevant age range). We detected EBV DNA in peripheral blood B cells and showed in one case that the infection was restricted to the small population of nonclassical, germinal center-independent memory B cells (IgD(+) CD27(+)). Detection of EBV small RNAs, latent membrane protein 2, and EBV nuclear antigen 3C expression in peripheral blood suggests full latent viral gene expression in this population. Analysis of EBV DNA in serial samples showed variability over time, suggesting cycles of infection and loss. Our results demonstrate that short-term EBV persistence can occur in the absence of a germinal center reaction and a classical memory B-cell population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103163      PMCID: PMC1193576          DOI: 10.1128/JVI.79.17.11128-11134.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

Authors:  Donna Hochberg; Jaap M Middeldorp; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

2.  Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes.

Authors:  L Qu; D T Rowe
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.

Authors:  R J Tierney; N Steven; L S Young; A B Rickinson
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Maintenance of long term gamma-herpesvirus B cell latency is dependent on CD40-mediated development of memory B cells.

Authors:  In-Jeong Kim; Emilio Flaño; David L Woodland; Frances E Lund; Troy D Randall; Marcia A Blackman
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

Review 5.  Hypermutation in human B cells in vivo and in vitro.

Authors:  Sandra Weller; Ahmad Faili; Said Aoufouchi; Quetin Guéranger; Moritz Braun; Claude-Agnès Reynaud; Jean-Claude Weill
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

6.  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.

Authors:  J P DiSanto; J Y Bonnefoy; J F Gauchat; A Fischer; G de Saint Basile
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

7.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

8.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

Authors:  A Aruffo; M Farrington; D Hollenbaugh; X Li; A Milatovich; S Nonoyama; J Bajorath; L S Grosmaire; R Stenkamp; M Neubauer
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

9.  Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients.

Authors:  Paul A Hopwood; Louise Brooks; Rachael Parratt; Beverly J Hunt; Maria Bokhari; J Alero Thomas; Magdi Yacoub; Dorothy H Crawford; Bokhari Maria; Thomas J Alero; Yacoub Magdi
Journal:  Transplantation       Date:  2002-07-27       Impact factor: 4.939

10.  Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen.

Authors:  Stephanie Kruetzmann; M Manuela Rosado; Holger Weber; Ulrich Germing; Olivier Tournilhac; Hans-Hartmut Peter; Reinhard Berner; Anke Peters; Thomas Boehm; Alessandro Plebani; Isabella Quinti; Rita Carsetti
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

View more
  6 in total

1.  The intersection of Epstein-Barr virus with the germinal center.

Authors:  Jill E Roughan; David A Thorley-Lawson
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

2.  A virtual look at Epstein-Barr virus infection: biological interpretations.

Authors:  Karen A Duca; Michael Shapiro; Edgar Delgado-Eckert; Vey Hadinoto; Abdul S Jarrah; Reinhard Laubenbacher; Kichol Lee; Katherine Luzuriaga; Nicholas F Polys; David A Thorley-Lawson
Journal:  PLoS Pathog       Date:  2007-10-19       Impact factor: 6.823

3.  Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.

Authors:  Madlen Loebel; Maren Eckey; Franziska Sotzny; Elisabeth Hahn; Sandra Bauer; Patricia Grabowski; Johannes Zerweck; Pavlo Holenya; Leif G Hanitsch; Kirsten Wittke; Peter Borchmann; Jens-Ulrich Rüffer; Falk Hiepe; Klemens Ruprecht; Uta Behrends; Carola Meindl; Hans-Dieter Volk; Ulf Reimer; Carmen Scheibenbogen
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

4.  The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.

Authors:  James Heather; Kirsty Flower; Samine Isaac; Alison J Sinclair
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

5.  Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology.

Authors:  Emily Heath; Noelia Begue-Pastor; Sridhar Chaganti; Debbie Croom-Carter; Claire Shannon-Lowe; Dieter Kube; Regina Feederle; Henri-Jacques Delecluse; Alan B Rickinson; Andrew I Bell
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

Review 6.  Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Jonathan Kerr
Journal:  Biomolecules       Date:  2020-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.